CHF Solutions (NSDQ:CHFS) shares ticked down today despite third-quarter results that topped the consensus revenue forecast. The Eden Prairie, Minn.-based blood management technology developer posted losses of -$4.3 million, or -$2.08 per share, on sales of $1.9 million for the three months ended Sept. 30, 2020, for a minor bottom-line slide on sales growth of 52.1%. […]
Blood Management
Haemonetics posts Street-beating Q2
Haemonetics (NYSE:HAE) shares dipped slightly on second-quarter results that topped the consensus forecast. The Boston-based blood management technology developer posted profits of $48.1 million, or 94¢ per share, on sales of $209.5 million for the three months ended Sept. 26, 2020, for a 28.3% bottom-line gain on a sales decline of -17.1%. Adjusted to exclude one-time […]
Masimo to acquire Lidco for $40.1M
Masimo (NSDQ:MASI) today confirmed that it is set to acquire advanced hemodynamic monitoring device maker Lidco for approximately $40.1 million. Both companies’ boards confirmed in an announcement that they agreed on the terms of a recommended cash offer to be made by Masimo for the entire issued and to be issued share capital of Lidco, totaling […]
6 early medical devices that might make your spine tingle
Medical Design & Outsourcing has made an annual effort during “spooky season” to shed light on some early medical devices and innovations and the museums that hold them, but this year is a bit different. Last year, we visited the Earl Bakken Museum’s backroom to get a look at early medical devices. A few years ago, we […]
FDA panel advises against assurable effectiveness of Neovasc Reducer
Neovasc (NSDQ:NVCN) announced that an FDA advisory panel voted against reasonable assurance of effectiveness for its Reducer system. The FDA’s Circulatory System Devices Advisory Panel voted 1 to 17 “against” on the issue of “a reasonable assurance of effectiveness,” according to a news release. “We would like to thank the FDA, the panel and members of […]
Magnolia Medical touts results of blood contamination study
Magnolia Medical Technologies today touted “unprecedented” results from a clinical study of its Steripath in sepsis testing. Seattle-based Magnolia Medical’s Steripath, a blood culture contamination product, was being evaluated for its impact in reducing false-positive blood culture results in sepsis testing, according to a news release. Results of the study were presented by Stanford Healthcare’s […]
CHF Solutions seeks patent for new Aquadex SmartFlow tech
CHF Solutions (NSDQ:CHFS) announced today that it submitted a patent application for a new advance to its Aquadex SmartFlow system. Eden Prairie, Minn.-based CHF Solutions develops Aquadex SmartFlow consoles for removing excess fluid from patients suffering from hypervolemia (fluid overload), which have recently been in demand due to capabilities in treating patients with COVID-19. Get the full […]
Philips touts post-stent imaging study results
Royal Philips (NYSE:PHG) announced today that one-year results of its Define PCI study that reported improved outcomes and less recurrent angina. The Define PCI study assessed the level of residual ischemia found in patients following a percutaneous coronary intervention (PCI) using a blinded instant wave-free ratio (iFR) pullback measurement, which is a guidance technology unique to […]
CytoSorbents wins $1.1M DoD contract for universal plasma
CytoSorbents (OTC:CTSO) announced today that the U.S. Army has awarded it a $1.1 million contract to develop its HemoDefend-BGA adsorber. HemoDefend-BGA can rapidly remove more than 99% of anti-A and anti-B antibodies from plasma to create a “universal plasma” that could be administered to anyone, irrespective of blood type, while maintaining critical coagulation activity, according to […]
FDA clears Haemonetics’ plasma collection system
Haemonetics (NYSE:HAE) announced that it received FDA 510(k) clearance for its NexSys PCS system with Persona technology. Boston-based Haemonetics’ new, proprietary Persona technology customizes plasma collection based on an individual donor’s body composition, according to a news release. NexSys PCS (plasma collection system) with Persona is intended for use as an automated cell separator system and […]
FDA labels another BD Alaris recall Class I
The FDA announced today that the August recall of a Becton Dickinson (NYSE:BDX) Alaris pump module is Class I, the most serious kind. BD Alaris pump module model 8100 and the Alaris pump module door assembly replacement kits (part numbers 49000346, 49000239, 49000438 and 49000439) were included in the Aug. 4 recall. Those models and parts were […]
